These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2874520)
1. An in vivo pharmacological method for the quantitative evaluation of the central effects of alpha 1 adrenoceptor agonists and antagonists. Menon MK; Kodama CK; Kling AS; Fitten J Neuropharmacology; 1986 May; 25(5):503-8. PubMed ID: 2874520 [TBL] [Abstract][Full Text] [Related]
2. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Haapalinna A; Leino T; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451 [TBL] [Abstract][Full Text] [Related]
3. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists. Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954 [TBL] [Abstract][Full Text] [Related]
4. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats. Srinivasan J; Schmidt WJ J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426 [TBL] [Abstract][Full Text] [Related]
5. A novel in vivo test for drugs affecting central serotonergic and adrenergic systems. Rawlow A; King RG Eur J Pharmacol; 1990 Dec; 191(3):263-72. PubMed ID: 1982266 [TBL] [Abstract][Full Text] [Related]
6. Interactions between the putative calcium entry promotor Bay k 8644 and pressor responses produced by alpha 1- and alpha 2-adrenoceptor agonists in the pithed normotensive rat. Wilffert B; van Heiningen PN; Mathy MJ; de Jonge A; Thoolen MJ; Timmermans PB; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):76-82. PubMed ID: 6083459 [TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord. Bervoets K; Millan MJ J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554 [TBL] [Abstract][Full Text] [Related]
8. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730 [TBL] [Abstract][Full Text] [Related]
9. Effects of the irreversible alpha-adrenoceptor antagonists phenoxybenzamine and benextramine on the effectiveness of nifedipine in inhibiting alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in pithed rats. Timmermans PB; Thoolen MJ; Mathy MJ; Wilffert B; de Jonge A; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):404-13. PubMed ID: 2993928 [TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist. Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719 [TBL] [Abstract][Full Text] [Related]
11. Modification of certain pharmacological effects of ethanol by lipophilic alpha-1 adrenergic agonists. Menon MK; Dinovo EC; Haddox VG Life Sci; 1987 Sep; 41(13):1599-610. PubMed ID: 2887999 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the alpha-adrenoceptors mediating positive inotropy of rat left atria by use of selective agonists and antagonists. Williamson KL; Broadley KJ Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):181-98. PubMed ID: 2883945 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556 [TBL] [Abstract][Full Text] [Related]
14. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist. Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420 [TBL] [Abstract][Full Text] [Related]
15. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes. Akers I; Coates J; Drew GM; Sullivan AT Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300 [TBL] [Abstract][Full Text] [Related]
16. Influence of respiratory acidosis or alkalosis on pressor responses mediated by alpha 1- and alpha 2-adrenoceptors in pithed normotensive rats. Korstanje C; Mathy MJ; van Charldorp K; de Jonge A; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):187-92. PubMed ID: 2865684 [TBL] [Abstract][Full Text] [Related]
17. Peripheral postsynaptic alpha-adrenoceptor blocking properties of some new dihydrobenzofurane and imidazoline derivatives in pithed rats. Mouillé P; Dabiré H; Joly G; Schmitt H Arzneimittelforschung; 1984; 34(12):1749-52. PubMed ID: 6152168 [TBL] [Abstract][Full Text] [Related]
18. Differences between full and partial alpha-adrenoceptor agonists in eliciting phasic and tonic types of responses in the longitudinal smooth muscle of the rat portal vein. Schwietert HR; Wilhelm D; Wilffert B; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):206-12. PubMed ID: 1682821 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of postsynaptic alpha2-adrenoceptors of the dog mesenteric and rat femoral veins. Paiva MQ; Morato M; Moura D; Guimarães S Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):165-70. PubMed ID: 10494886 [TBL] [Abstract][Full Text] [Related]
20. Antagonism of the hypothermic effect of clozapine in mice by centrally-active alpha 2-adrenergic antagonists and alpha 1-adrenergic agonists. Menon MK; Lloyd RL; Fitten LJ Psychopharmacology (Berl); 1990; 101(1):67-72. PubMed ID: 1971449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]